ArticleFrontiers in immunology2024

Cost-effectiveness of additional serplulimab to chemotherapy in metastatic squamous non-small cell lung cancer patients.

Hanrui Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.